2007
DOI: 10.1120/jacmp.v8i2.2350
|View full text |Cite
|
Sign up to set email alerts
|

Experimental validation of the Eclipse AAA algorithm

Abstract: The present study evaluates the performance of a newly released photon‐beam dose calculation algorithm that is incorporated into an established treatment planning system (TPS). We compared the analytical anisotropic algorithm (AAA) factory‐commissioned with “golden beam data” for Varian linear accelerators with measurements performed at two institutions using 6‐MV and 15‐MV beams. The TG‐53 evaluation regions and criteria were used to evaluate profiles measured in a water phantom for a wide variety of clinical… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
62
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 70 publications
(65 citation statements)
references
References 19 publications
(27 reference statements)
1
62
0
Order By: Relevance
“…However, common metrics may reduce the sensitivity of systems involved in patient‐specific QA processes 15 , 25 , 26 , 48 , 49 , 50 . A recent study by Nelms et al (50) suggested performing a more stringent gamma analysis, restricting traditional tolerances.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, common metrics may reduce the sensitivity of systems involved in patient‐specific QA processes 15 , 25 , 26 , 48 , 49 , 50 . A recent study by Nelms et al (50) suggested performing a more stringent gamma analysis, restricting traditional tolerances.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the pretreatment QA measurement‐based process must be considered to ensure the correct information flow from TPS plan calculation to treatment delivery in the linac by means of the record and verify system (R&V). The usual method to perform this QA consists of comparing dose distribution measurements acquired with phantoms/detectors of regular geometries with TPS calculations made under the same conditions 13 , 14 , 15 . Volumetric treatments have incorporated specifically developed solutions for these techniques 16 , 17 .…”
Section: Introductionmentioning
confidence: 99%
“…While reliable agreement between the calculated and measured/reconstructed dose in a geometrical phantom is the basis for the dosimetric commissioning of an IMRT system, its value for the meaningful patient‐specific, end‐to‐end testing is less clear. With the prevalent 3% globally normalized dose error and 3 mm DTA threshold criteria in particular, 3 , 4 , 5 y‐analysis passing rates for either per‐beam, single‐plane (6) or quasi‐3D (7) array geometries, had weak — and counter‐intuitive, if any — correlation with the conventional clinical DVH metrics. Instances of the 3%/3mm passing rate metric's failure to detect systematic errors are numerous 6 , 7 , 8 , 9 .…”
Section: Introductionmentioning
confidence: 99%
“…A typical institutional criteria for gamma analysis 7 , 8 is to use values of DTA=±3mm and % absolute dose difference =±3%. These values give very good passing rates (as expected), but also show little change in the number of failed points as the parameters MSF and ρ are varied.…”
Section: Methodsmentioning
confidence: 62%